StonvexLoading…
StonvexStonvexStonvexCore line items from ROP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.10B | $7.90B | $5.84B | $3.83B |
Operating Income | $569.60M | $2.24B | $1.65B | $1.07B |
Net Income | $508.90M | $1.54B | $1.11B | $709.40M |
EPS (Diluted) | $4.87 | $14.20 | $10.23 | $6.55 |
Total Assets | $34.55B | $34.58B | $34.58B | $33.22B |
Total Liabilities | $15.73B | $14.70B | $14.59B | $13.59B |
Cash & Equivalents | $382.90M | $297.40M | $320.00M | $242.40M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 102.40M | 106.60M | 108.30M | 108.30M |